Inventor · disambiguated record
Fei Sun
Also filed as: SUN FEI
29 granted patents·23 pending applications·41 citations·filing 2003–2025
93Inventor score
Files withCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD16MEDSHINE DISCOVERY INC6ZHANG XITIAN6FUJIAN AKEYLINK BIOTECHNOLOGY CO LTD5FUJIAN COSUNTER PHARMACEUTICAL CO LTD2
Top patents by PatentIndex Score
52 records- 0191US9962388B2Pyrrolopyrimidine compounds used as TLR7 agonistCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2015·Granted May 8, 2018·14 cites·10 claims
- 0291US9090661B2Inhibitors of hepatitis C virus replicationMERCK SHARP & DOHME·Filed 2014·Granted Jul 28, 2015·18 cites·16 claims
- 0387US10519133B2Vinyl compounds as FGFR and VEGFR inhibitorsMEDSHINE DISCOVERY INC·Filed 2016·Granted Dec 31, 2019·4 cites·16 claims
- 0480US12054482B2TLR8 agonistCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Aug 6, 2024·1 cites·11 claims
- 0578US10555949B2Pyrrolopyrimidine compounds used as TLR7 agonistCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted Feb 11, 2020·2 cites·14 claims
- 0676US10548883B2Benzotriazole-derived α and β-unsaturated amide compound used as TGF-β RI inhibitorGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2017·Granted Feb 4, 2020·1 cites·19 claims
- 0767US12275788B2Single-domain antibodies against CD33 and constructs thereofLEGEND BIOTECH IRELAND LTD·Filed 2019·Granted Apr 15, 2025·0 cites·18 claims
- 0862US11008331B2Hepatitis B virus surface antigen inhibitorFUJIAN COSUNTER PHARMACEUTICAL CO LTD·Filed 2018·Granted May 18, 2021·1 cites·23 claims
- 0962US2025230156A1Crystal form of allyl-containing methylpyridopyrimidine compoundMEDSHINE DISCOVERY INC·Filed 2023·Application pending·0 cites
- 1061US12215153B1Anti-receptor expressed on lymphoid tissues (RELT) recombinant monoclonal antibody and preparation method and use thereofTONGJI HOSPITAL TONGJI MEDICAL COLLEGE OF HUST·Filed 2024·Granted Feb 4, 2025·0 cites·2 claims
- 1161US10442811B2Crystal form A of 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-D] pyrimidin-4-amine, preparation process and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Oct 15, 2019·0 cites·20 claims
- 1260US12441764B2Phosphorylated antigen and antibody at SER23 site of PGAM1 protein as well as preparation methods and applicationsTONGJI HOSPITAL AFFILIATED WITH TONGJI MEDICAL COLLEGE OF HUAZHONG UNIV OF SCIENCE AND TECHNOLOGY·Filed 2024·Granted Oct 14, 2025·0 cites·3 claims
- 1359US11807647B2Crystal form of hepatitis B surface antigen inhibitor and application thereofFUJIAN AKEYLINK BIOTECHNOLOGY CO LTD·Filed 2020·Granted Nov 7, 2023·0 cites·14 claims
- 1459US10947245B2Crystal form A of 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine for inhibiting toll-like receptor activityCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Mar 16, 2021·0 cites·20 claims
- 1558US2024217953A1Bicyclic substituted aromatic carboxylic acid compoundsCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2022·Application pending·0 cites
- 1657US2020239484A1Method for preparing pyrrolo[3,2,-d]pyrimidine compound, and intermediates thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Application pending·0 cites
- 1757US2023235330A1Conjugate of double-stranded sirna analogueCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
- 1856US10654856B2Method for preparing pyrrolo[3,2-D]pyrimidine compound, and intermediates thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted May 19, 2020·0 cites·17 claims
- 1956US2020368241A1Tlr7 agonist maleate salt, crystalline forms c, d and e thereof, preparation methods and uses of maleate salt and crystalline formsCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Application pending·0 cites
- 2056US2025154166A1Hepatitis b virus surface antigen inhibitorFUJIAN AKEYLINK BIOTECHNOLOGY CO LTD·Filed 2025·Application pending·0 cites
- 2156US2020197409A1Hepatitis b virus surface antigen inhibitorFUJIAN COSUNTER PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 2255US12103936B2Crystal form of hepatitis B surface antigen inhibitorFUJIAN AKEYLINK BIOTECHNOLOGY CO LTD·Filed 2019·Granted Oct 1, 2024·0 cites·6 claims
- 2355US2023220386A1Sirna conjugate, double-stranded sirna conjugate, salt thereof and application thereofMEDSHINE DISCOVERY INC·Filed 2020·Application pending·0 cites
- 2454US12435101B2Isochroman compoundZHEJIANG YANGLI PHARMACEUTICAL TECH CO LTD·Filed 2021·Granted Oct 7, 2025·0 cites·14 claims
- 2554US2024033278A9Conjugate group and conjugateMEDSHINE DISCOVERY INC·Filed 2021·Application pending·0 cites
- 2652US10683296B2TLR7 agonist trifluoroacetate salt and crystalline form B thereof, preparation methods and usesCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Jun 16, 2020·0 cites·12 claims
- 2752US2023183263A1Combination for treating hepatitis bFUJIAN AKEYLINK BIOTECHNOLOGY CO LTD·Filed 2021·Application pending·0 cites
- 2851US10780091B2TLR7 agonist maleate salt, crystalline forms C, D and E thereof, preparation methods and uses of maleate salt and crystalline formsCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Sep 22, 2020·0 cites·16 claims
- 2951US7264948B2Polypeptides for increasing mutant CFTR channel activityUNIV PITTSBURGH·Filed 2003·Granted Sep 4, 2007·0 cites·5 claims
- 3051US2022323400A1Inhibitors of sglt and uses thereofUNIV MICHIGAN REGENTS·Filed 2020·Application pending·0 cites
- 3150US12071435B2TLR8 agonistCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Aug 27, 2024·0 cites·14 claims
- 3250US2025171474A1Crystal form of isochroman compoundZHEJIANG YANGLI PHARMACEUTICAL TECH CO LTD·Filed 2023·Application pending·0 cites
- 3349US11505601B2Compositions and methods using a single-domain antibody binding transferrin and protein A for increasing protein half-life in serumNANJING LEGEND BIOTECH CO LTD·Filed 2017·Granted Nov 22, 2022·0 cites·14 claims
- 3449US2025332273A1Spider silk protein-based hydrogel enables injectable and sustained delivery of protein therapeutics for neuroprotection and axon regenerationUNIV HONG KONG SCIENCE & TECH·Filed 2025·Application pending·0 cites
- 3548US11572372B2Anti-HBVtetrahydroisoxazolo[4,3-c]pyridine compoundsCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted Feb 7, 2023·0 cites·19 claims
- 3647US12391707B2Preparation method for oxazepine compoundFUJIAN AKEYLINK BIOTECHNOLOGY CO LTD·Filed 2020·Granted Aug 19, 2025·0 cites·17 claims
- 3747US2018132458A1Transgenic animal models for cystic fibrosisUNIV MICHIGAN REGENTS·Filed 2017·Application pending·0 cites
- 3846US9504690B2Tetracyclic xanthene derivatives and methods of use thereof for the treatment of viral diseasesCOBURN CRAIG A·Filed 2012·Granted Nov 29, 2016·0 cites·14 claims
- 3946US2022144850A1Indolo heptamyl oxime analogue as parp inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Application pending·0 cites
- 4045US2021062219A1Smartbac baculovirus expression system and application thereofINST BIOPHYSICS CAS·Filed 2018·Application pending·0 cites
- 4141US10676478B27-(thiazol-5-yl) pyrrolopyrimidine compound as TLR7 agonistCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted Jun 9, 2020·0 cites·11 claims
- 4241US2016129077A1Use of recombinant ganoderma immunoregulatory protein (rLZ-8) in preparation of drug for treating melanomaZHANG XITIAN·Filed 2014·Application pending·0 cites
- 4340US10647755B2Photoresponsive protein hydrogels and methods and uses thereofUNIV HONG KONG SCI & TECH·Filed 2018·Granted May 12, 2020·0 cites·20 claims
- 4440US10508103B2Benzimidazole-linked indole compound acting as novel divalent IAP antagonistMEDSHINE DISCOVERY INC·Filed 2017·Granted Dec 17, 2019·0 cites·32 claims
- 4540US9789158B2Applications of recombined Ganoderma lucidum immunoregulation protein in preparing drugs for treating tissue fibrosisZHANG XITIAN·Filed 2014·Granted Oct 17, 2017·0 cites·2 claims
- 4640US2015023994A1RECOMBINANT GANODERMA LUCIDIUM IMMUNOMODULATORY PROTEIN (rLZ-8) AND USES THEREOFSUN FEI·Filed 2014·Application pending·0 cites
- 4738US12077566B2Mutants of recombinant immunoregulatory protein of Ganoderma lucidum and applications thereofZHANG XITIAN·Filed 2018·Granted Sep 3, 2024·0 cites·9 claims
- 4835US2011009597A1RECOMBINANT GANODERMA LUCIDIUM IMMUNOMODULATORY PROTEIN (rLZ-8) AND USES THEREOFSUN FEI·Filed 2010·Application pending·0 cites
- 4933US2018148452A1Toll-like receptor-7 agonistMEDSHINE DISCOVERY INC·Filed 2015·Application pending·0 cites
- 5032US2016289280A1Fusion protein of recombinant ganoderma immunoregulatory protein and human serum albumin, preparation method thereof, and application thereofZHANG XITIAN·Filed 2014·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Fei Sun files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →